Ad is loading...
PABVX
Price
$19.12
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VMVAX
Price
$89.64
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

PABVX vs VMVAX

Header iconPABVX vs VMVAX Comparison
Open Charts PABVX vs VMVAXBanner chart's image
Principal MidCap Value I R5
Price$19.12
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$89.64
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PABVX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PABVX vs. VMVAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABVX is a Buy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. PABVX (2.92B). VMVAX pays higher dividends than PABVX: VMVAX (2.14) vs PABVX (1.01). PABVX was incepted earlier than VMVAX: PABVX (20 years) vs VMVAX (13 years). PABVX is a more actively managed with annual turnover of: 49.90 vs. VMVAX (22.00). PABVX has a lower initial minimum investment than VMVAX: PABVX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 28.25 vs. PABVX (21.96). VMVAX return over 5 years is better than : 50.95 vs. PABVX (38.26).
PABVXVMVAXPABVX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years13 years-
Gain YTD17.80719.62391%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.92B30.9B9%
Annual Yield % from dividends1.012.1447%
Returns for 1 year21.9628.2578%
Returns for 3 years1.6116.9410%
Returns for 5 years38.2650.9575%
Returns for 10 years22.8798.2923%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSMVX30.150.48
+1.62%
Wilshire Small Company Value Instl
TEMTX28.450.24
+0.85%
Franklin Mutual Shares C
SAMVX12.98N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
IEMGX10.00N/A
N/A
Voya Multi-Manager Emerging Markets Eq I
GMOEX24.89-0.04
-0.16%
GMO Emerging Markets III